Biography

Dr. Burak Hacıhanefioğlu was born in İstanbul, Turkey on April 25, 1969. He graduated from Hacettepe University Faculty of Medicine in 1993. He completed his residency in Obstetrics and Gynecology at Cerrahpaşa Faculty of Medicine, İstanbul University in December, 1998. During his Obstetrics and Gynecology residency program, he finished a research project titled ”Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome”.

Dr. Burak Hacıhanefioğlu worked on another research project about impaired mechanisms of folliculogenesis and ovulation in women with polycystic ovary syndrome in Orebro, Sweden, on 1999.

He worked as a research fellow at Reproductive Medicine Unit in Newham General Hospital, London, UK between the years 2000-2002. During his fellowship, Dr.Burak Hacıhanefioğlu worked on a research project titled ‘’Investigation of apoptotic and cell cycle pathways in granulosa cells of women with polycystic ovary syndrome’’. He involved in the running of Polycystic Ovary Clinic in Newham General Hospital between 2000-2004.

Dr.Burak Hacıhanefioğlu has been in private practice since 2002. He is currently working at ” Women’s Health and Research & Polycystic Ovary Center”, in İstanbul, Turkey.

Dr.Burak Hacıhanefioğlu is a member of ”The Endocrine Society”, ”Androgen Excess and PCOS Society” and ”Turkish Society of Obstetrics and Gynecology”. Some of his research articles published in peer-reviewed journals listed below;

Gynecol Endocrinol. 2013 Apr;29(4):361-4. Association of anthropometric, androgenic and insulin-related features with polymorphisms in exon 8 of SHBG gene in women with polyacystic ovary syndrome. Hacıhanefioğlu B, Aybey B, Hakan Özön Y, Berkil H, Karşıdağ K.

J Clin Endocrinol Metab. 2008 Mar;93(3):881-7. Granulosa cell survival and proliferation are altered in polycystic ovary syndrome. Das M, Djahanbakhch O, Hacihanefioglu B, Saridogan E, Ikram M, Ghali L, Raveendran M, Storey A.

CPD Clinical Biochemistry. 2003; 5(1):8-13. Pathogenesis and metabolic manifestations of polycystic ovary syndrome. Burak Hacihanefioglu & Sudha Bulusu.

Fertil Steril. 2002 Mar;77(3):526-8. Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome. Hacihanefioglu BSomunkiran AMahmutoglu ISercelik AToptani SKervancioglu E.

Fertil Steril. 2000 Jun;73(6):1261-2. Polycystic ovary syndrome nomenclature: chaos?  Hacihanefioglu Burak.

Fertil Steril. 2000 Feb;73(2):261-5. Influence of insulin resistance on total renin level in normotensive women with polycystic ovary syndrome. Hacihanefioglu B, Seyisoglu  HKarsidag KElter KAksu FYilmaz TGurol AO.

Fertil Steril. 1999 Mar;71(3):425-30. Role of mutations Trp8⇒Arg and Ile15⇒Thr of the human luteinizing hormone beta-subunit in women with polycystiic ovary syndrome. Elter K, Erel CT, Cine N, Ozbek U, Hacihanefioglu B, Ertungealp E.